Justin D. Gover, Chief Executive Officer at GW PHARMACEUTICALS PLC (GWPH), sold 22,620 shares at $7.96 ($188K) on 2019-01-02, disclosed to the SEC on 2019-01-04.
Open-market sale of $188k GWPH by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.96 | 2,400 | $19K | 10.1% |
| 2 | $8.14 | 3,600 | $29K | 15.6% |
| 3 | $8.25 | 1,200 | $10K | 5.3% |
| 4 | $8.43 | 14,220 | $120K | 63.6% |
| 5 | $8.52 | 1,200 | $10K | 5.4% |
| Total | $8.33 avg | 22,620 |
| $188K |
| 100% |
| Filing → |
| GWPH | SELL | 2020-03-04 | $477K | — | Filing → |
| GWPH | SELL | 2020-02-28 | $194K | — | Filing → |
| GWPH | SELL | 2020-02-05 | $3.9M | — | Filing → |